News

Charity urges action to improve tolerance of mental health problems

12-May-08

A mental health charity has called for a campaign to educate the public about mental health issues after DoH statistics revealed that public opinion is deeply unsympathetic and 'bigoted'.

The statistics, published last week, showed that one in eight people would not want to live next door to someone who has been mentally ill, and that almost 60 per cent of people describe someone with a mental health problem as ‘someone who has to be kept in a psychiatric or mental hospital'.

A third of the public think people with mental health problems should not have the same rights to a job as other people. 

Mental health charity Rethink's director of public affairs Paul Corry said: ‘These findings show just how bad the situation can be for people with mental health problems. Archaic, bigoted opinions about mental illness still prevail and clearly demonstrate the urgent need for action to change people's views.'

nick.bostock@haymarket.com

Comment below and tell us what you think 

 

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Healthcare Republic Forums

 

Registrar

A question of capacity

Medicolegal advisor, Dr John Holden addresses some dilemmas on consent that may be faced by GPs. Read more

Workplace-based assessment

The WPBA should be seen as a developmental process, says the RCGP's Dr Jane Mamelok. Read more

Professional development - The role of an educational supervisor

Working as an educational supervisor can be stimulating and rewarding, says Dr Alexander Williams. Read more

Show all articles

 

Latest Clinical Articles

Primary hyperparathyroidism

Contributed by Mr David Scott-Coombes, consultant endocrine surgeon at the University Hospital of Wa... Read more

Clinical Review - Headache in children

Contributed by Dr David Kernick, a GPSI in headache, based in Exeter. Read more

Carpal tunnel syndrome

Section 1: Epidemiology and aetiology Read more

Show all clinical articles

MIMS Product News

Toviaz

New drug - Toviaz

Pfizer has launched Toviaz (fesoterodine), a once-daily treatment for the symptoms of overactive bla... Read more

New drug - Tasigna

Novartis has launched Tasigna (nilotinib), a new antineoplastic agent for Philadelphia chromosome po... Read more

Ciproxin licensed for UTI in children

The licence for Ciproxin (ciprofloxacin) has been extended to include the second- and third-line tr... Read more

Jobs

 

Job of the Week